Viking Therapeutics, Inc 10-Q for FY2026 Q2
Viking Therapeutics, Inc. (VKTX)
10-Q
2026-07-29
For: 2026-06-30
View Original
Added on
July 29, 2026
About this 10-Q
Viking Therapeutics, Inc filed this 10-Q on July 29, 2026, covering the quarter ended June 30, 2026 (FY2026 Q2).
Headline figures
Quarter ended June 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $0
- compared with $0 a year earlier
- Net loss
- $128.02M
- compared with a net loss of $65.56M a year earlier
- Diluted EPS
- -$1.10
- compared with -$0.58 a year earlier